AMED 26.50 Amedisys Inc $AMED Hit a 52 week high o
Post# of 31
Posted On: 11/05/2014 5:55:23 AM
AMED 26.50 Amedisys Inc $AMED Hit a 52 week high of 26.57 Closing the day 11/04/14 at 26.50 +0.69 +2.67% With a day low of 25.60 and a total volume of 413,500.
AMED Recent Posts: http://investorshangout.com/Amedisys-Inc-AMED-53302/
AMED Amedisys Inc Recent Headline News
Amedisys Up 61.4% Since SmarTrend Uptrend Call (AMED)
Comtex SmarTrend(R) - Tue Nov 04, 9:40AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 61.39% as of today's recent price of $25.83.
AMED: 26.50 (+0.69)
Your Best Stocks Will Be in the Best Industries - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Nov 04, 3:01AM CST
Your Best Stocks Will Be in the Best Industries - Screen of the Week
BCC: 36.84 (+0.18), HNI: 46.39 (-0.12), ALDW: 20.01 (-0.19), AMED: 26.50 (+0.69), FLWS: 8.03 (+0.02)
Is Emerson Electric (EMR) Likely to Miss on Earnings Again? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:51PM CDT
Emerson Electric Co. (EMR), a global technological solutions provider, is set to report fourth-quarter and full-year 2014 results on Nov 4, before the opening bell.
BBRY: 10.26 (+0.01), EMR: 64.19 (-0.32), AMED: 26.50 (+0.69), AAPL: 108.60 (-0.80)
Amedysis Turns Around with Q3 Earnings Beat, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 1:50PM CDT
Following Amedisys' (AMED) promising earnings announcement, the company's stock price surged 16.2% to eventually close at $25.28 yesterday.
AMSG: 52.28 (-0.13), USPH: 43.19 (-0.08), RDNT: 9.62 (+0.09), AMED: 26.50 (+0.69)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.90 (-0.01), ACMP: 62.09 (-1.12), AMAG: 34.10 (+0.28), AMED: 26.50 (+0.69), ACCO: 8.41 (+0.08)
Amedisys (AMED) Upgraded From Hold to Buy
at The Street - Fri Oct 31, 8:09AM CDT
Amedisys (AMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AMED: 26.50 (+0.69)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.00 (-0.07), ABMD: 31.85 (-0.67), BGFV: 12.69 (+0.19), RDCM: 8.90 (+0.53), AMED: 26.50 (+0.69), MRCY: 13.67 (-0.03), OMER: 17.12 (-0.21), ESBF: 18.59 (-0.04), EVOK: 6.43 (-0.09), IQNT: 17.50 (+0.47), KONA: 22.15 (-0.26), TQNT: 22.16 (-0.20), LAKE: 13.25 (-0.53), SAJA: 6.50 (+0.02)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.41 (-0.11), ZLTQ: 26.44 (+0.73), EA: 40.64 (-0.32), AMED: 26.50 (+0.69)
Critical Alerts For General Electric, Amedisys Inc, RF Micro Devices, JC Penney and SolarCity Released By InvestorsObserver
PR Newswire - Thu Oct 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GE, AMED, RFMD, JCP and SCTY.
GE: 25.70 (unch), SCTY: 56.96 (-1.81), JCP: 7.32 (-0.24), AMED: 26.50 (+0.69), RFMD: 13.35 (-0.04)
Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:21AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise nearly 16% on the day.
AMSG: 52.28 (-0.13), USPH: 43.19 (-0.08), RDNT: 9.62 (+0.09), AMED: 26.50 (+0.69)
Upgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Oct 30, 6:53AM CDT
Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $25.22 on volume of 1.6 million shares, above average daily volume of 269,000. Amedisys (NASDAQ:AMED) is currently priced 31.4% above its average consensus analyst price target of $17.31. The stock should find initial support at its 50-day moving average (MA) of $20.78 and further support at its 200-day MA of $16.87.
AMED: 26.50 (+0.69)
Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 26.50 (+0.69)
Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 26.50 (+0.69)
35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 26.50 (+0.69)
5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.80 (+0.13), RYAM: 28.03 (-0.51), CLF: 11.33 (+0.35), AMED: 26.50 (+0.69), LOCK: 16.87 (-0.29)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 61.36 (-0.75), AMED: 26.50 (+0.69), HLS: 39.58 (-0.37), GTIV: 19.34 (-0.23)
Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 26.50 (+0.69)
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 26.50 (+0.69)
AMED Recent Posts: http://investorshangout.com/Amedisys-Inc-AMED-53302/
AMED Amedisys Inc Recent Headline News
Amedisys Up 61.4% Since SmarTrend Uptrend Call (AMED)
Comtex SmarTrend(R) - Tue Nov 04, 9:40AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 61.39% as of today's recent price of $25.83.
AMED: 26.50 (+0.69)
Your Best Stocks Will Be in the Best Industries - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Nov 04, 3:01AM CST
Your Best Stocks Will Be in the Best Industries - Screen of the Week
BCC: 36.84 (+0.18), HNI: 46.39 (-0.12), ALDW: 20.01 (-0.19), AMED: 26.50 (+0.69), FLWS: 8.03 (+0.02)
Is Emerson Electric (EMR) Likely to Miss on Earnings Again? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:51PM CDT
Emerson Electric Co. (EMR), a global technological solutions provider, is set to report fourth-quarter and full-year 2014 results on Nov 4, before the opening bell.
BBRY: 10.26 (+0.01), EMR: 64.19 (-0.32), AMED: 26.50 (+0.69), AAPL: 108.60 (-0.80)
Amedysis Turns Around with Q3 Earnings Beat, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 1:50PM CDT
Following Amedisys' (AMED) promising earnings announcement, the company's stock price surged 16.2% to eventually close at $25.28 yesterday.
AMSG: 52.28 (-0.13), USPH: 43.19 (-0.08), RDNT: 9.62 (+0.09), AMED: 26.50 (+0.69)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.90 (-0.01), ACMP: 62.09 (-1.12), AMAG: 34.10 (+0.28), AMED: 26.50 (+0.69), ACCO: 8.41 (+0.08)
Amedisys (AMED) Upgraded From Hold to Buy
at The Street - Fri Oct 31, 8:09AM CDT
Amedisys (AMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AMED: 26.50 (+0.69)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.00 (-0.07), ABMD: 31.85 (-0.67), BGFV: 12.69 (+0.19), RDCM: 8.90 (+0.53), AMED: 26.50 (+0.69), MRCY: 13.67 (-0.03), OMER: 17.12 (-0.21), ESBF: 18.59 (-0.04), EVOK: 6.43 (-0.09), IQNT: 17.50 (+0.47), KONA: 22.15 (-0.26), TQNT: 22.16 (-0.20), LAKE: 13.25 (-0.53), SAJA: 6.50 (+0.02)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.41 (-0.11), ZLTQ: 26.44 (+0.73), EA: 40.64 (-0.32), AMED: 26.50 (+0.69)
Critical Alerts For General Electric, Amedisys Inc, RF Micro Devices, JC Penney and SolarCity Released By InvestorsObserver
PR Newswire - Thu Oct 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GE, AMED, RFMD, JCP and SCTY.
GE: 25.70 (unch), SCTY: 56.96 (-1.81), JCP: 7.32 (-0.24), AMED: 26.50 (+0.69), RFMD: 13.35 (-0.04)
Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:21AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise nearly 16% on the day.
AMSG: 52.28 (-0.13), USPH: 43.19 (-0.08), RDNT: 9.62 (+0.09), AMED: 26.50 (+0.69)
Upgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Oct 30, 6:53AM CDT
Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $25.22 on volume of 1.6 million shares, above average daily volume of 269,000. Amedisys (NASDAQ:AMED) is currently priced 31.4% above its average consensus analyst price target of $17.31. The stock should find initial support at its 50-day moving average (MA) of $20.78 and further support at its 200-day MA of $16.87.
AMED: 26.50 (+0.69)
Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 26.50 (+0.69)
Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 26.50 (+0.69)
35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 26.50 (+0.69)
5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.80 (+0.13), RYAM: 28.03 (-0.51), CLF: 11.33 (+0.35), AMED: 26.50 (+0.69), LOCK: 16.87 (-0.29)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 61.36 (-0.75), AMED: 26.50 (+0.69), HLS: 39.58 (-0.37), GTIV: 19.34 (-0.23)
Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 26.50 (+0.69)
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 26.50 (+0.69)
(0)
(0)